Health Condition 1: L409- Psoriasis, unspecified
Conditions
Interventions
Intervention1: Kali group, calcarea group, lycopodium and sulphur: Potency: 6C, 30C, 200C, 1M, LM 0/1, LM 0/2.
Repetition: as per the need of patient and observation will be done at every 5th, 7th, an
Sponsors
dr Nirali Modi
Eligibility
Inclusion criteria
Inclusion criteria: 1. Pre-diagnosed and cases with clinical presentation of Psoriasis were selected randomly. 2. Cases from age 18 to 65 will be included in the study irrespective of gender. 3. Diagnosed cases of Psoriasis which were under treatment by other schools of medicines, but desired to have homoeopathic treatment. 4. Patient with other modern medicine will be observed with decrease in intake of medicine other than homoeopathy and how much of changes are seen on basis of PASI with relation to DCPR. 5. Diagnosis shall be done with PASI score where PASI Score from 0- 40 will be selected. 6. Medicine from Kali Group, Calcarea group, Sulphur and lycopodium will be selected for the research.
Exclusion criteria
Exclusion criteria: 1. Cases with severe systematic disease were excluded. 2. Cases with irreversible pathology except Psoriasis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in the Psoriasis Area and Severity Index (PASI) score to the end of the treatment period. A decrease in the PASI score will indicate reduction in disease severity and successful therapeutic intervention.Timepoint: Baseline (Week 0), Mid-treatment (Week 18), and End of treatment (Week 36) | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactNirali Chirag Modi
dr.v.h.dave homoeopathic medical college
Outcome results
None listed